Abstract:SESSION TITLE: Tuesday Abstract Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: 10/22/2019 01:00 PM - 02:00 PM PURPOSE: The aim of this study is to determine if biomarkers can play clinically significant role in the prediction for risk stratification of acute pulmonary embolism (APE). METHODS: Patients diagnosed with APE by computed tomography pulmonary arteriography (CTPA) were enrolled from August 2016 to April 2019 in the prospective, cross-section observational study. Demographic features, clinical manifestations, laboratory data, imaging features and pulmonary embolism severity index (PESI) scores were collected on admission. The patients were divided into high-risk and non-high-risk groups according to 2014 European Society of Cardiology (ESC) guidelines for APE. The differences between the patients in two groups were compared and a predictive model for high risk APE was established using univariate and multivariate logistic regression analyses. The accuracy in predicting the poor outcomes of the patients with APE using these parameters was compared in a Receiver-Operating Characteristic (ROC) plot. RESULTS: A total of 106 patients, 59 males (55.7%), 47 females (44.3%), age range of 20 to 87 years were included whose cohort with the high risk group of 32 cases and the non-high risk group of 74 demonstrated significant differences with higher incidence of underlying pulmonary disease, thrombus burden, frequency of acute exacerbation of chronic obstructive pulmonary disease (COPD), degree of dyspnea, level of systolic pressure, bilateral embolism, PESI score, ratio of neutrophils to lymphocytes (NLR), prothrombin time (PT), lactic acid dehydrogenase (LDH), C-reactive protein (CRP) and serum level of growth and differentiation factor-15 (GDF-15) in the high risk group (p<0.05). GDF-15 (OR=1.022, 95%CI:1.003∼1.041) and LDH (OR=1.041, 95%CI:1.007∼1.076) were independently associated with high-risk of APE in the multivariate logistic regression model. The cut-off values of serum levels of GDF-15 and LDH for APE patients with higher risk were 1017.4 pg/ml and 388.5 U/L and the corresponding sensitivity and specificity were 90.9%, 86.5 % and 68.2%, 97.3% respectively. CONCLUSIONS: Higher serum levels of LDH and GDF-15 at admission increase the risk of APE leading to poor outcomes. The serum levels of LDH and GDF-15 could therefore play a significant role as predictive factors of APE in patients with high risk factors. CLINICAL IMPLICATIONS: APE is a serious clinical condition which can lead to high morbidity and mortality. Risk stratification could predict 30-day mortality in patients with APE, however, further improvements can be achieved using biomarkers. DISCLOSURES: No relevant relationships by aamer Chughtai, source=Web Response no disclosure on file for XIAO GAN; No relevant relationships by Lu Guo, source=Web Response no disclosure on file for YICEN HAN; no disclosure on file for Jingyan Liu; no disclosure on file for shengkun Peng; no disclosure on file for Hong Pu; no disclosure on file for jing zhang; no disclosure on file for Jing Zhang

Evaluation of Hemogram Parameters in the Diagnosis of Pulmonary Embolism: Immature Granulocytes and Other New Tips

Clinical analysis of acute pulmonary embolism in 49 cases

Clinical Analysis of 106 Cases Pulmonary Embolism

Compromised Natural Killer Cells in Pulmonary Embolism.

Advances in Pulmonary Embolism Biomarkers

Decreased Thrombin Generation is Associated with Increased Thrombin Generation Biomarkers and Blood Cellular Indices in Pulmonary Embolism

Prognostic Role of Serial Electrocardiographic Changes in Patients with Acute Pulmonary Embolism. Data from the Italian Pulmonary Embolism Registry

The prognostic value of blood cellular indices in pulmonary embolism

Neutrophil levels upon admission for the assessment of acute pulmonary embolism with intermediate- and high-risk: an indicator of thrombosis and inflammation

Evaluation of pan-Immuno-Inflammation value for In-hospital mortality in acute pulmonary embolism patients

Quantitative Evaluation of Cardiopulmonary Functional Reserve in Treated Patients with Pulmonary Embolism

Correlation Between Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio with Risk Stratification Indicators and Thrombus Burden in Patients with Moderate-to-High Risk Acute Pulmonary Embolism, and Changes After Treatment

Imaging and Biomarkers: The Assesment of Pulmonary Embolism Risk and Early Mortality

Perfusion index: could it be a new tool for early identification of pulmonary embolism severity?

The diagnostic significance of signal peptide-complement C1r/C1s, Uegf, and Bmp1-epidermal growth factor domain-containing protein-1 levels in pulmonary embolism

Quantitative volumetric computed tomography embolic analysis, the Qanadli score, biomarkers, and clinical prognosis in patients with acute pulmonary embolism

ROLE OF BIOMARKERS IN PREDICTION FOR RISK STRATIFICATION OF ACUTE PULMONARY EMBOLISM

Blood Cell Parameters Combined with Inflammatory Markers in the Early Diagnosis of Pulmonary Embolism

The Clinical Analysis and Treatment of Acute Pulmonary Embolism

Role of serum biomarkers in predicting management strategies for acute pulmonary embolism

A Focus on the Triglyceride–Glucose Index and Pan-Immune Inflammation Value